These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23178230)

  • 1. Anti-inflammatory treatment in schizophrenia.
    Müller N; Myint AM; Krause D; Weidinger E; Schwarz MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():146-53. PubMed ID: 23178230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological treatment options for schizophrenia.
    Müller N; Myint AM; Schwarz MJ
    Curr Pharm Biotechnol; 2012 Jun; 13(8):1606-13. PubMed ID: 22283758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological treatment options for schizophrenia].
    Müller N; Krause D; Weidinger E; Schwarz M
    Fortschr Neurol Psychiatr; 2014 Apr; 82(4):210-9. PubMed ID: 24710677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation in schizophrenia.
    Müller N; Myint AM; Schwarz MJ
    Adv Protein Chem Struct Biol; 2012; 88():49-68. PubMed ID: 22814706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
    Müller N
    Curr Opin Investig Drugs; 2010 Jan; 11(1):31-42. PubMed ID: 20047157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects.
    Müller N; Myint AM; Schwarz MJ
    Curr Pharm Des; 2011; 17(2):130-6. PubMed ID: 21361867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.
    Muller N; Schwarz M
    Neurotox Res; 2006 Oct; 10(2):131-48. PubMed ID: 17062375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 inhibition in schizophrenia and major depression.
    Müller N; Schwarz MJ
    Curr Pharm Des; 2008; 14(14):1452-65. PubMed ID: 18537668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view.
    Miüller N; Schwarz MJ
    J Neural Transm Suppl; 2007; (72):269-80. PubMed ID: 17982903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients.
    Myint AM; Schwarz MJ; Verkerk R; Mueller HH; Zach J; Scharpé S; Steinbusch HW; Leonard BE; Kim YK
    Brain Behav Immun; 2011 Nov; 25(8):1576-81. PubMed ID: 21620952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New prospects for antipsychotic treatment - the role of the kynurenine pathway].
    Karakuła-Juchnowicz H; Flis M; Szymona K; Kuczyńska M; Stelmach E; Kowal-Popczak A
    Psychiatr Pol; 2014; 48(6):1167-77. PubMed ID: 25717486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders--relation to drug treatment.
    Müller N; Myint AM; Schwarz MJ
    Dialogues Clin Neurosci; 2009; 11(3):319-32. PubMed ID: 19877499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune System and Schizophrenia.
    Müller N; Schwarz MJ
    Curr Immunol Rev; 2010 Aug; 6(3):213-220. PubMed ID: 21057585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.
    Müller N; Schwarz MJ
    Mol Psychiatry; 2007 Nov; 12(11):988-1000. PubMed ID: 17457312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders.
    Müller N; Schwarz MJ
    Expert Rev Neurother; 2006 Jul; 6(7):1017-38. PubMed ID: 16831116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The kynurenic acid hypothesis - a new look at etiopathogenesis and treatment of schizophrenia].
    Flis M; Szymona K; Morylowska-Topolska J; Urbańska A; Krukow P; Kandefer-Szerszeń M; Zdzisińska B; Urbańska EM; Karakuła-Juchnowicz H
    Pol Merkur Lekarski; 2016 Sep; 41(243):160-164. PubMed ID: 27755520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression.
    Anderson G; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():5-19. PubMed ID: 22800757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of anti-inflammatory treatment in psychiatric disorders.
    Müller N
    Psychiatr Danub; 2013 Sep; 25(3):292-8. PubMed ID: 24048400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro.
    Zakrocka I; Targowska-Duda KM; Wnorowski A; Kocki T; Jóźwiak K; Turski WA
    Neurotox Res; 2019 Jan; 35(1):244-254. PubMed ID: 30178287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory biomarkers and depression.
    Müller N; Myint AM; Schwarz MJ
    Neurotox Res; 2011 Feb; 19(2):308-18. PubMed ID: 20658274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.